Summary & Overview
CPT 3322F: Cardiac Device Follow-Up Performance Measure
CPT code 3322F is a CPT Category II performance measure tied to cardiac device management and follow-up. It captures whether specific performance criteria related to implantable cardiac devices have been met during ambulatory device clinic visits or electrophysiology assessments. As a performance measure code, 3322F supports quality tracking and reporting rather than describing a discrete billable procedure; it is used alongside clinical visit or device-interrogation services to document compliance with recommended device-care processes.
Nationally, performance measure codes like 3322F matter because they inform quality programs, payor reporting, and value-based contracting. Payors commonly involved in these analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what 3322F represents, the clinical context for its use in device clinics, and the national payers typically relevant to coverage and reporting. The publication will also outline where to find benchmarks and policy updates, summarize clinical context for device follow-up, and note which data elements are not available in the source input.
Data not available in the input.
Billing Code Overview
CPT code 3322F represents a performance measure related to cardiac device management as indicated by the code description. The service type is cardiac device follow-up and performance assessment, typically delivered in outpatient cardiology clinics, device clinics, or specialized electrophysiology offices. The typical site of service is ambulatory outpatient settings where device interrogation and clinical assessment occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic bradycardia, symptomatic sinus node dysfunction, high-grade atrioventricular block, or recurrent syncope being evaluated for permanent pacemaker therapy. The clinical workflow begins with a cardiology consultation in an outpatient electrophysiology clinic or inpatient cardiology service. The patient undergoes pre-procedure evaluation including history, physical exam, medication review, review of prior ECGs and telemetry, and relevant labs (basic metabolic panel, coagulation studies). Informed consent is obtained for device implantation. On the day of the procedure, the patient is brought to the electrophysiology lab or cardiac catheterization suite. Under conscious sedation or monitored anesthesia care, venous access is obtained (commonly via the subclavian or cephalic vein), transvenous pacing leads are advanced under fluoroscopic guidance to the right atrium and/or right ventricle, lead parameters are tested, and the generator is implanted in a subcutaneous or subpectoral pocket. Device programming and testing are performed prior to incision closure. Post-procedure, the patient is monitored for complications (hematoma, lead dislodgement, pneumothorax, infection) and receives discharge instructions with device clinic follow-up for wound check and device interrogation. Typical sites of service are the electrophysiology laboratory, cardiac catheterization laboratory, or inpatient operating room for urgent or emergent implants.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated evaluation and management service by the same physician during a postoperative period |